Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DABRAFENIB vs DALBAVANCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DABRAFENIB vs DALBAVANCIN: Safety Overview

Metric DABRAFENIB DALBAVANCIN
Total FAERS Reports 19,305 1,107
Deaths Reported 4,165 54
Death Rate 21.6% 4.9%
Hospitalizations 5,325 288
Average Patient Age 58.3 yrs 61.0 yrs
% Female Patients 48.0% 46.7%
FDA Approval Date Mar 16, 2023 May 23, 2014
Manufacturer Novartis Pharmaceuticals Corporation Fresenius Kabi USA, LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription